Cargando…
Cancer drugs: high price, uncertain value
A study published in The BMJ this week shows how most new cancer drugs are failing to deliver any clinically meaningful benefit. It’s time for Europe to raise the evidence bar before market approval, finds Deborah Cohen
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695518/ https://www.ncbi.nlm.nih.gov/pubmed/28978508 http://dx.doi.org/10.1136/bmj.j4543 |
_version_ | 1783280327652802560 |
---|---|
author | Cohen, Deborah |
author_facet | Cohen, Deborah |
author_sort | Cohen, Deborah |
collection | PubMed |
description | A study published in The BMJ this week shows how most new cancer drugs are failing to deliver any clinically meaningful benefit. It’s time for Europe to raise the evidence bar before market approval, finds Deborah Cohen |
format | Online Article Text |
id | pubmed-5695518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56955182017-11-24 Cancer drugs: high price, uncertain value Cohen, Deborah BMJ Feature A study published in The BMJ this week shows how most new cancer drugs are failing to deliver any clinically meaningful benefit. It’s time for Europe to raise the evidence bar before market approval, finds Deborah Cohen BMJ Publishing Group Ltd. 2017-11-20 /pmc/articles/PMC5695518/ /pubmed/28978508 http://dx.doi.org/10.1136/bmj.j4543 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Feature Cohen, Deborah Cancer drugs: high price, uncertain value |
title | Cancer drugs: high price, uncertain value |
title_full | Cancer drugs: high price, uncertain value |
title_fullStr | Cancer drugs: high price, uncertain value |
title_full_unstemmed | Cancer drugs: high price, uncertain value |
title_short | Cancer drugs: high price, uncertain value |
title_sort | cancer drugs: high price, uncertain value |
topic | Feature |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695518/ https://www.ncbi.nlm.nih.gov/pubmed/28978508 http://dx.doi.org/10.1136/bmj.j4543 |
work_keys_str_mv | AT cohendeborah cancerdrugshighpriceuncertainvalue |